MGF (2mg) protocols focus on this IGF-1 splice variant peptide, known as Mechano Growth Factor, which is studied for its potential role in muscle repair, satellite cell activation, and localized tissue regeneration following mechanical stress or training. MGF may support enhanced recovery and muscle tissue remodeling. This guide outlines a subcutaneous administration approach optimized for the 2 mg vial format.
Concise summary of the peptide regimen.
Suggested approach for the 2 mg vial format.
Mechano Growth Factor (MGF) is a splice variant of the IGF-1 gene that is expressed in response to mechanical stress, such as resistance training or muscle damage. Unlike systemic IGF-1, MGF is believed to act locally within muscle tissue.
It activates satellite cells—muscle stem cells responsible for repair and growth—and may promote muscle fiber repair and hypertrophy. MGF is thought to initiate early-stage regeneration processes, making it distinct from other growth-related peptides that act more systemically. Preclinical research suggests it plays a key role in muscle adaptation following resistance exercise.
Observations based on preclinical and early research.
Potential Benefits:
Possible Side Effects: